ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
D035843:Biomedical Research; D003029:Coagulants; D003850:Deoxyribonuclease I; D005340:Fibrinogen; D005342:Fibrinolysis; D009525:Niacin; D009539:Nicotinic Acids; D010600:Pharmacology; D010958:Plasminogen; D013299:Streptodornase and Streptokinase; D013300:Streptokinase; D013806:Theophylline; D015912:Thrombolytic Therapy
D003029:Coagulants; D009539:Nicotinic Acids; D009525:Niacin; D005340:Fibrinogen; D010958:Plasminogen; D013806:Theophylline; D013299:Streptodornase and Streptokinase; D003850:Deoxyribonuclease I; D013300:Streptokinase
CLINICAL RESEARCH; FIBRINOGEN; FIBRINOLYSIS; NICOTINIC ACID; PHARMACOLOGY; PLASMINOGEN; STREPTODORNASE AND STREPTOKINASE; THEOPHYLLINE